Trials / Unknown
UnknownNCT00327483
Web Based Renal Transplant Patient Medication Education
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (planned)
- Sponsor
- Agency for Healthcare Research and Quality (AHRQ) · Federal
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.
Detailed description
Transplant recipients are particularly vulnerable to medication errors because of the large number of chronic drugs needed to prevent rejection and treat comorbidities. Compliance failures directly compromise patient safety through acute immunologic events and premature graft loss. For society, the loss of invested fiscal and organic (organs) resources is catastrophic. As the unique constant in the chain of people who provide, modify and consume prescription medications, health information technology should be focused on empowering the patient to prevent medication errors. Our principal clinical hypothesis is that HIT can be proven to improve patient safety by minimizing medication errors. Specific aims address the creation of new knowledge and evidence ( in a renal transplant population) of benefits of widely applicable HIT tools. Web enabled education of two groups, new (\<6 months) and established (\> 6 months), kidney transplant recipients is proposed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Internet based education software |
Timeline
- Start date
- 2005-07-01
- Completion
- 2006-04-01
- First posted
- 2006-05-18
- Last updated
- 2006-05-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00327483. Inclusion in this directory is not an endorsement.